Medibank Private Ltd.

As of June 30, 2026, Medibank Private Ltd. carries a market capitalization of 13.69B, placing it among publicly traded companies globally. Its enterprise value stands at 13.06B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medibank Private Ltd.'s next confirmed earnings release is scheduled for February 24, 2027.

As of June 30, 2026, Medibank Private Ltd. has 2.75B shares outstanding.

As of June 30, 2026, Medibank Private Ltd. trades at a trailing price-to-earnings ratio of 21.43. The price-to-sales ratio is 1.47, and the price-to-book ratio stands at 5.63.

These figures are as of June 30, 2026. The EV/Sales ratio of 1.40 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 13.06B versus a market cap of 13.69B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Medibank Private Ltd. posted a return on equity (ROE) of 26.80, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 13.51, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 24.23, useful for judging operating efficiency across full business cycles. The company generates approximately 1.87M in revenue per employee across its workforce of 5,001.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Medibank Private Ltd. recorded 281.60M in income tax expense. That works out to an effective tax rate of 30.35, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 927.90M, leaving 638.70M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Medibank Private Ltd.'s stock has gained approximately 4.89% over the past 52 weeks. The 50-day moving average sits at 4.69, while the 200-day moving average is 4.71.

Over the twelve months ended June 30, 2026, Medibank Private Ltd. generated 9.34B in revenue and converted that into 638.70M in net income, yielding earnings per share of 0.23.

As of June 30, 2026, Medibank Private Ltd. holds 876.40M in cash and equivalents against 273.90M in total debt, resulting in a net debt position of -534.50M.

These figures cover the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Medibank Private Ltd. paid dividends of 0.19 per share. The dividend payout ratio of 79.00 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 4.42, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Medibank Private Ltd. shareholders.